Metraipolis › archive › dc_b172bb6d0bca

TLR4-Mediated Immune Dysfunction Links MASLD and Parkinson's Disease: Insights from an Omics-Based Network Analysis — Europe PMC PMID:41874031

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41874031
DOI
10.3390/neurosci7020028
License (as archived)
solo-consultazione
Archived
2026-11-05T12:49:21.185Z
SHA-256 of the archived text
dd5a45b8bb711d6ca2117cff89a3507090a071719ab3496d3548c5f5ed2df040
Stable URL of this page
https://metraipolis.com/documento/dc_b172bb6d0bca

How to cite

TLR4-Mediated Immune Dysfunction Links MASLD and Parkinson's Disease: Insights from an Omics-Based Network Analysis — Europe PMC PMID:41874031 — Europe PMC (en), https://europepmc.org/article/MED/41874031 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b172bb6d0bca (Metraipolis archive dc_b172bb6d0bca, sha256 dd5a45b8bb711d6ca2117cff89a3507090a071719ab3496d3548c5f5ed2df040)
BibTeX
@misc{dcb172bb6d0bca,
  title = {TLR4-Mediated Immune Dysfunction Links MASLD and Parkinson's Disease: Insights from an Omics-Based Network Analysis — Europe PMC PMID:41874031},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41874031},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b172bb6d0bca; sha256 dd5a45b8bb711d6ca2117cff89a3507090a071719ab3496d3548c5f5ed2df040},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41874031. Agents can read the archived copy with the MCP tool read_document.